RYR2 and early-onset autosomal dominant Alzheimer disease: These data are also consistent with our results, and we can suggest that, in a 5xFAD mouse model of Alzheimer's disease, inhibition of RyR2-dependent Ca2+ exit from the ER alone leads to a greater therapeutic effect than blocking both RyR2 and IP3R1 channels.